AstraZeneca taps gene pioneer Venter for huge drug-hunting sweep

CAMBRIDGE, England (Reuters) - AstraZeneca, working with genome pioneer Craig Venter, is launching a massive gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines.

from Reuters: Science News http://ift.tt/1SnrWq9
via IFTTT